Big Pharma's focus on profit is behind medicine shortages, superbug threat
The profit-oriented approach in medicine development leads to shortages of essential medicines and poses a threat to public health.
Cost of developing new drugs may be far lower than industry claims, trial reveals
The true cost of developing medicine may be far less than estimated by the pharmaceutical industry, sparking the need for transparency in clinical trial spending.
Big Pharma's focus on profit is behind medicine shortages, superbug threat
The profit-oriented approach in medicine development leads to shortages of essential medicines and poses a threat to public health.
Cost of developing new drugs may be far lower than industry claims, trial reveals
The true cost of developing medicine may be far less than estimated by the pharmaceutical industry, sparking the need for transparency in clinical trial spending.